Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11293919rdf:typepubmed:Citationlld:pubmed
pubmed-article:11293919lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11293919lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:11293919lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:11293919lifeskim:mentionsumls-concept:C0032460lld:lifeskim
pubmed-article:11293919lifeskim:mentionsumls-concept:C0005210lld:lifeskim
pubmed-article:11293919lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:11293919pubmed:issue1lld:pubmed
pubmed-article:11293919pubmed:dateCreated2001-4-10lld:pubmed
pubmed-article:11293919pubmed:abstractTextThe aim of this study was to determine the influence of body weight on circulating plasma levels of beta-endorphin and insulin in women with polycystic ovary disease (PCOD), as well as the correlation between the plasma levels of beta-endorphin and insulin. One-hundred and sixty-seven consecutive subjects with PCOD were recruited, 117 of whom had normal weight (body mass index (BMI) < 25) while 50 were obese (BMI > 25). A venous blood sample was taken and plasma concentrations of beta-endorphin, insulin, gonadotropins, prolactin, progesterone, 17 beta-estradiol, estrone, androgens, dehydroepiandrosterone sulfate and sex hormone-binding globulin (SHBG) were measured. Mean beta-endorphin and insulin plasma levels were significantly higher (p < 0.05) in obese PCOD women than in non-obese ones. Correlation analysis showed a positive association between insulin and beta-endorphin, beta-endorphin and BMI (and weight), insulin and BMI (and weight), and a negative correlation was found between insulin and SHBG. A weak association was found between beta-endorphin and luteinizing hormone (LH) in peripheral plasma. Stratified and linear regression analysis showed that plasma beta-endorphin concentrations correlate more with BMI than with insulinemia.lld:pubmed
pubmed-article:11293919pubmed:languageenglld:pubmed
pubmed-article:11293919pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11293919pubmed:citationSubsetIMlld:pubmed
pubmed-article:11293919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11293919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11293919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11293919pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11293919pubmed:statusMEDLINElld:pubmed
pubmed-article:11293919pubmed:monthFeblld:pubmed
pubmed-article:11293919pubmed:issn0951-3590lld:pubmed
pubmed-article:11293919pubmed:authorpubmed-author:FerrerJJlld:pubmed
pubmed-article:11293919pubmed:authorpubmed-author:DíazFFlld:pubmed
pubmed-article:11293919pubmed:authorpubmed-author:GuerreroMMlld:pubmed
pubmed-article:11293919pubmed:authorpubmed-author:AlonsoFFlld:pubmed
pubmed-article:11293919pubmed:authorpubmed-author:CorderoJJlld:pubmed
pubmed-article:11293919pubmed:authorpubmed-author:Martínez-Guis...lld:pubmed
pubmed-article:11293919pubmed:issnTypePrintlld:pubmed
pubmed-article:11293919pubmed:volume15lld:pubmed
pubmed-article:11293919pubmed:ownerNLMlld:pubmed
pubmed-article:11293919pubmed:authorsCompleteYlld:pubmed
pubmed-article:11293919pubmed:pagination14-22lld:pubmed
pubmed-article:11293919pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:meshHeadingpubmed-meshheading:11293919...lld:pubmed
pubmed-article:11293919pubmed:year2001lld:pubmed
pubmed-article:11293919pubmed:articleTitlePlasma beta-endorphin levels in obese and non-obese patients with polycystic ovary disease.lld:pubmed
pubmed-article:11293919pubmed:affiliationDepartment of Obstetrics and Gynecology, General Yagüe Hospital, Burgos, Spain.lld:pubmed
pubmed-article:11293919pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11293919pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11293919lld:pubmed